Ryan Specialty Holdings Inc. (NYSE:RYAN) Receives $55.69 Consensus Target Price from Brokerages

Shares of Ryan Specialty Holdings Inc. (NYSE:RYAN) have been given a consensus recommendation of “Hold” by the eighteen analysts that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, five have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $54.50.

A number of research analysts recently commented on RYAN shares. Piper Sandler decreased their price target on Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating on the stock in a research report on Friday, February 13th. Cantor Fitzgerald cut their price objective on shares of Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating for the company in a research report on Tuesday, February 17th. Wells Fargo & Company reduced their price objective on shares of Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. BMO Capital Markets lowered shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $66.00 to $43.00 in a report on Wednesday, February 25th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating for the company in a research report on Wednesday, January 7th.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $33.46 on Thursday. The firm has a market cap of $8.84 billion, a PE ratio of 79.66, a price-to-earnings-growth ratio of 0.87 and a beta of 0.65. The company has a debt-to-equity ratio of 2.62, a current ratio of 0.98 and a quick ratio of 0.98. The stock’s fifty day moving average price is $42.06 and its two-hundred day moving average price is $49.97. Ryan Specialty has a one year low of $32.64 and a one year high of $77.16.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The company had revenue of $751.21 million for the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The business’s revenue was up 13.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 earnings per share. As a group, research analysts expect that Ryan Specialty will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th were paid a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a yield of 1.6%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date of this dividend was Tuesday, February 24th. Ryan Specialty’s payout ratio is 123.81%.

Insider Buying and Selling

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was purchased at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the completion of the purchase, the director directly owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. This trade represents a 6.33% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 52.21% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ryan Specialty

Several hedge funds and other institutional investors have recently modified their holdings of RYAN. Westview Management dba Westview Investment Advisors bought a new stake in shares of Ryan Specialty during the fourth quarter worth $2,082,000. JPMorgan Chase & Co. increased its holdings in shares of Ryan Specialty by 149.7% during the third quarter. JPMorgan Chase & Co. now owns 421,330 shares of the company’s stock worth $23,746,000 after buying an additional 252,582 shares in the last quarter. Geneva Capital Management LLC lifted its stake in shares of Ryan Specialty by 11.2% in the 3rd quarter. Geneva Capital Management LLC now owns 535,742 shares of the company’s stock valued at $30,194,000 after acquiring an additional 53,810 shares during the last quarter. Beck Mack & Oliver LLC bought a new position in shares of Ryan Specialty in the 3rd quarter valued at $2,818,000. Finally, TD Asset Management Inc boosted its holdings in shares of Ryan Specialty by 2,181.8% during the 3rd quarter. TD Asset Management Inc now owns 205,133 shares of the company’s stock valued at $11,561,000 after acquiring an additional 196,143 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.